research use only
Cat.No.P1107
Amino-acid Sequence
CAS No. 1176306-10-7
| Storage (From the date of receipt) | 3 years-20°C powder | ||
|
In vitro |
DMSO
: 100 mg/mL
(116.95 mM);
Water : 100 mg/mL Ethanol : Insoluble |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | Alamandine is a component of the renin-angiotensin system, which regulates blood pressure. |
|---|
In vitro |
||||
| In vitro | Alamandine decreases leptin secretion and expression in isolated adipocytes mediated by Gq, c-Src, p38 mitogen-activated protein and IκB activation, also induces nitric oxide expression via inducible nitric oxidase synthase and plasminogen activator inhibitor 1 expression in isolated adipocytes. |
|||
|---|---|---|---|---|
| Cell Research | Cell lines | adipocytes isolated from rats, 3T3L-1 adipocytes | ||
| Concentrations | 0.01, 0.1, 1, 10, 100, 1000 nM | |||
| Incubation Time | 24 h | |||
| Method | Isolated adipocytes are incubated with alamandine for 24 h. Secreted leptin levels are determined using a leptin immunoassay kit according to the manufacturer’s protocol. |
|||
In Vivo |
||
| In vivo |
Moderately concentrated alamandine reduces blood leptin levels in vivo. |
|
|---|---|---|
| Animal Research | Animal Models | Wistar rats (10-week-old) |
| Dosages | 576, 57.6, 5.76, or 0.576 µg/kg | |
| Administration | i.p. | |
References |
|
| Molecular Formula | C40H62N12O9 |
|---|---|
| Molecular Weight | 855 |
| CAS No. | 1176306-10-7 |
| Appearance | White Powder |
| Peptide Content (by %N) | ≥80% |
| Single Impurity (by HPLC) | ≤1.0% |
| Assay (By Anhydrous, Acetic Acid-free) | 95.0~105.0% |
| MS | Consistent |
| Packing | plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. |
| Storage (From the date of receipt) |
3 years-20°C powder |
| Shipping | Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.) |